Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide

Stopped PharmaMar has decided to end this study due to the slow recruitment rate of the trial

Conditions

• Multiple Myeloma

Interventions

• DRUG: plitidepsin
• DRUG: Bortezomib
• DRUG: Dexamethasone

Sponsor

PharmaMar